Author:
Iwamoto Takuya,Monma Fumihiko,Fujieda Atsushi,Nakatani Kaname,Katayama Naoyuki,Okuda Masahiro
Subject
Pharmacology (medical),Pharmacology
Reference9 articles.
1. Interaction between tacrolimus and lansoprazole, but not rabeprazole in living-donor liver transplant patients with defects of CYP2C19 and CYP3A5;Hosohata;Drug Metab Pharmacokinet,2008
2. Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients;Miura;Biopharm Drug Dispos,2007
3. Lansoprazole-tacrolimus interaction in Japanese transplant recipient with CYP2C19 polymorphism;Takahashi;Ann Pharmacother,2004
4. Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A;Jeong;Antimicrob Agents Chemother,2009
5. Clinical pharmacokinetics of voriconazole;Leveque;Int J Antimicrob Agents,2006
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献